World hits milestone of 10 billion COVID vaccine doses administered, but less than 10% of people in low-income countries have had a first jab

México Noticias Noticias

World hits milestone of 10 billion COVID vaccine doses administered, but less than 10% of people in low-income countries have had a first jab
México Últimas Noticias,México Titulares
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 73 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 32%
  • Publisher: 97%

Ten billion COVID-19 vaccine doses have been administered across the world. Only 9.8% of people in low-income countries have received a first vaccine dose, while wealthy countries have had three doses.

The world reached a COVID-19 vaccination milestone Friday of 10 billion doses administered globally, according to Our World in Data, but wealthier countries account for the vast majority, while poorer ones have been left behind.

The highly infectious omicron variant, which was detected in December and has gone on to become the leading variant in most places, is just such an example. Omicron has caused many breakthrough cases in people who are fully vaccinated and even had a booster dose, but those cases are usually mild or asymptomatic.

The WHO is targeting vaccinating 70% of the world’s population this year and has said reaching that goal would move the world out of the “acute phase” of the pandemic, the period in which it remains an international emergency. “If countries use all of these strategies and tools in a comprehensive way, we can end the acute phase of the pandemic this year — we can end COVID-19 as a global health emergency, and we can do it this year,” said Tedros, in a statement. iframe.twitter-tweet { width: 100% !important; } COVID cases and hospitalizations are declining in the U.S., according to a New York Times tracker, although deaths, which are a lagging indicator, are steadily climbing. The U.S.

• Novavax NVAX will supply 5 million doses of its protein-based COVID-19 vaccine to Israel as part of an advance purchase agreement, with the Israeli Ministry of Health also taking an option to buy an additional 5 million doses. Novavax is currently conducting two Phase 3 trials of the vaccine involving about 30,000 participants in the U.S. and Mexico, as well as a trial involving about 15,000 people in the U.K.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

MarketWatch /  🏆 3. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Hospital patient who refused COVID-19 vaccine denied heart transplantHospital patient who refused COVID-19 vaccine denied heart transplantA Boston hospital is defending itself after a man’s family claimed he was denied a new heart for refusing to be vaccinated against COVID-19.
Leer más »

Health check newsletter: England lets covid-19 rip: What happens next?Health check newsletter: England lets covid-19 rip: What happens next?As covid restrictions are relaxed in the UK, we look at how these new policies could play out
Leer más »

COVID-19 Through a Nurse’s LensCOVID-19 Through a Nurse’s LensAt the peak of New York’s crisis, a health-care worker brought her camera to the I.C.U.
Leer más »

23 active duty sailors in the US Navy discharged for refusing COVID-19 vaccine23 active duty sailors in the US Navy discharged for refusing COVID-19 vaccineThis marks the first time the Navy has thrown currently serving sailors out of the military over mandatory shots.
Leer más »

Blood test could reveal risk of having long-term health effects of COVID-19Blood test could reveal risk of having long-term health effects of COVID-19While long COVID-19 continues to cause medical problems for thousands of Utahns, new research suggests a blood test could one day help determine a person's risk for the perplexing condition.
Leer más »



Render Time: 2025-03-14 18:06:50